Lung Cancer Screening
- PMID: 26315517
- DOI: 10.1016/j.suc.2015.05.006
Lung Cancer Screening
Abstract
Screening for lung cancer in high-risk individuals with annual low-dose computed tomography has been shown to reduce lung cancer mortality by 20% and is recommended by multiple health care organizations. Lung cancer screening is not a specific test; it is a process that involves appropriate selection of high-risk individuals, careful interpretation and follow-up of imaging, and annual testing. Screening should be performed in the context of a multidisciplinary program experienced in the diagnosis and management of lung nodules and early-stage lung cancer.
Keywords: Low Dose CT; Multidisciplinary program; Screening; Smoking.
Published by Elsevier Inc.
Similar articles
-
Diagnostic performance of low-dose computed tomography screening for lung cancer over five years.J Thorac Oncol. 2014 Jul;9(7):935-939. doi: 10.1097/JTO.0000000000000200. J Thorac Oncol. 2014. PMID: 24922008
-
Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.Lung Cancer. 2010 Feb;67(2):177-83. doi: 10.1016/j.lungcan.2009.03.030. Epub 2009 May 7. Lung Cancer. 2010. PMID: 19427055
-
Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage.Ann Intern Med. 2014 Sep 16;161(6):445-6. doi: 10.7326/M14-1352. Ann Intern Med. 2014. PMID: 24957566 No abstract available.
-
Lung Cancer Screening: Why, When, and How?Radiol Clin North Am. 2017 Nov;55(6):1163-1181. doi: 10.1016/j.rcl.2017.06.003. Radiol Clin North Am. 2017. PMID: 28991558 Review.
-
Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.Clin Radiol. 2017 May;72(5):389-400. doi: 10.1016/j.crad.2016.12.021. Epub 2017 Feb 4. Clin Radiol. 2017. PMID: 28168954 Review.
Cited by
-
Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.Cancer Cell Int. 2020 Jan 3;20:2. doi: 10.1186/s12935-019-1065-x. eCollection 2020. Cancer Cell Int. 2020. PMID: 31911754 Free PMC article.
-
Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer.Onco Targets Ther. 2017 Jan 31;10:535-541. doi: 10.2147/OTT.S125108. eCollection 2017. Onco Targets Ther. 2017. PMID: 28203086 Free PMC article.
-
Rare occurrence of metastasis from lung cancer to the anus: case report and review of the literature.World J Surg Oncol. 2016 Jun 8;14(1):157. doi: 10.1186/s12957-016-0909-2. World J Surg Oncol. 2016. PMID: 27278524 Free PMC article. Review.
-
A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):86-95. doi: 10.1158/1055-9965.EPI-17-0478. Epub 2017 Nov 15. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29141854 Free PMC article.
-
Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.Lung Cancer. 2017 May;107:50-58. doi: 10.1016/j.lungcan.2016.06.003. Epub 2016 Jun 14. Lung Cancer. 2017. PMID: 27344275 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical